NIH-funded research R01 grant

N-acetylcysteine to rebalance brain chemistry and reduce heavy drinking in bipolar disorder with alcohol use

Official title: N-acetylcysteine for restoring glutamate/glutathione homeostasis and reducing heavy drinking in co-occurring bipolar and alcohol use disorders

Funded at Medical University of South Carolina · NIH-11430386 · Data updated 2026-11-12

This project tests a safe medication, N-acetylcysteine, to help people with bipolar disorder who drink heavily by stabilizing brain chemistry and reducing drinking.

More Alcohol Use research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMedical University of South Carolina
NIH-funded
Lab location1 site (Charleston, United States)
Project startSeptember 20, 2026
Project endAugust 31, 2031
Funding year2026
Award (this year)$674,482
NIH project number1R01AA033435-01
Project IDNIH-11430386 on NIH RePORTER

Who could benefit from this research

Could help

Adults diagnosed with bipolar disorder and a co-occurring alcohol use disorder who are seeking adjunctive treatment options.

Less likely to help

Individuals without BD or with alcohol use disorders not meeting trial criteria, or those intolerant to NAC, may not benefit.

What this research studies

People with bipolar disorder often struggle with alcohol use, which can worsen mood symptoms and overall outcomes. The study builds on prior work showing that N-acetylcysteine can help restore glutamate and glutathione balance in the brain and may lessen drinking and mood disturbance. Researchers will enroll participants with BD and co-occurring AUD to receive NAC versus placebo in a randomized design, using brain imaging and clinical assessments to track changes. If NAC helps, it could become an adjunctive therapy to improve mood stability and reduce alcohol use for this population.

Why it matters

Potential benefit: If successful, NAC could offer a safe add-on treatment to reduce heavy drinking and improve mood-related outcomes in people with BD and AUD.

How similar studies have gone: Prior trials suggest NAC is safe and can influence brain chemistry and some symptoms in BD or AUD, with mixed clinical results but a rationale for further study.

Where this research is happening

  • Medical University of South Carolina
    Charleston, United States
    Active

Researchers

  • Principal investigator: Prisciandaro, James Joseph — Medical University of South Carolina
  • Study coordinator: Prisciandaro, James Joseph

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.